The effect of iloprost and sildenafil, alone and in combination, on myocardial ischaemia and nitric oxide and irisin levels

Aim: Insufficient oxygen supply to organs and tissues due to reduced arterial or venous blood flow results in ischaemia, during which, although ATP production stops, AMP and adenosine continue to be produced from ATP. The fate of irisin, which causes the production of heat instead of ATP during isch...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cardiovascular Journal of Africa 2017-11, Vol.28 (6), p.389-396
Hauptverfasser: Yardim, Meltem, Kalkan, Ali Kemal, Aydin, Suna, Eren, Mehmet Nesimi, Temizturk, Zeki, Aydin, Suleyman, Azboy, Davut, Kuloglu, Tuncay
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 396
container_issue 6
container_start_page 389
container_title Cardiovascular Journal of Africa
container_volume 28
creator Yardim, Meltem
Kalkan, Ali Kemal
Aydin, Suna
Eren, Mehmet Nesimi
Temizturk, Zeki
Aydin, Suleyman
Azboy, Davut
Kuloglu, Tuncay
description Aim: Insufficient oxygen supply to organs and tissues due to reduced arterial or venous blood flow results in ischaemia, during which, although ATP production stops, AMP and adenosine continue to be produced from ATP. The fate of irisin, which causes the production of heat instead of ATP during ischaemia, is unknown. Iloprost and sildenafil are two pharmaceutical agents that mediate the resumption of reperfusion (blood supply) via vasodilatation during ischaemic conditions. Our study aimed to explore the effects of iloprost and sildenafil on irisin levels in the heart, liver and kidney tissues and whether these pharmaceutical agents had any impact on serum irisin and nitric oxide levels in rats with induced experimental myocardial ischaemia. Methods: The study included adult male Sprague-Dawley rats aged 10 months and weighing between 250 and 280 g. The animals were randomly allocated to eight groups, with five rats in each group. The groups were: sham (control), iloprost (ILO), sildenafil (SIL), ILO + SIL, myocardial ischaemia (MI), MI + ILO, MI + SIL and MI + ILO + SIL. The treatment protocols were implemented before inducing ischaemia, which was done by occluding the left coronary artery with a plastic ligature for 30 minutes. Following the reperfusion procedure, all rats were sacrificed after 24 hours, and their heart, liver and kidney tissues and blood samples were collected for analyses. An immunohistochemical method was used to measure the change in irisin levels, the ELISA method to quantify blood irisin levels, and Griess’ assay to determine nitric oxide (NO) levels in the serum and tissue. Myocardial ischaemia was confirmed based on the results of Masson’s trichrome staining, as well as levels of troponin and creatine kinase MB. Results: Irisin levels in biological tissue and serum dropped statistically significantly in the ischaemic group (MI), but were restored with ILO and SIL administration. Individual SIL administration was more potently restorative than individual ILO administration or the combined administration of the two agents. NO level, on the other hand, showed the opposite tendency, reaching the highest level in the MI group, and falling with the use of pharmaceutical agents. Conclusions: Individual or combined administration of ILO and SIL reduced myocardial ischaemia and NO levels, and increased irisin levels. Elevated levels of irisin obtained by drug administration could possibly contribute to accelerated wound recovery by local
doi_str_mv 10.5830/CVJA-2017-025
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5885053</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sabinet_id>10520/EJC-b2be3f645</sabinet_id><sourcerecordid>2032684254</sourcerecordid><originalsourceid>FETCH-LOGICAL-c449t-3930a6df337fc2070c48405d80e91a03d82e52718a9df15009104ea218919d703</originalsourceid><addsrcrecordid>eNpdkc1rFDEYhwdRbK0evUrAi0JH33zNJJdCWepHKXipXkM2ecdNySTrZLZY_OfNdNeinhKSJz_eX56meUnhnVQc3q--XZ63DGjfApOPmmPaKWihF_Jx3WstW6o0O2qelXIDwJjq5dPmiCkNnWT6uPl1vUGCw4BuJnkgIebtlMtMbPKkhOgx2SHEU2JjTnh_GhJxeVyHZOeQ0ynJiYx32dnJBxtJKG5jcQz2nk1hnoIj-Wfwh8dTKDUg4i3G8rx5MthY8MVhPWm-fri4Xn1qr758_Lw6v2qdEHpuueZgOz9w3g-OQQ9OKAHSK0BNLXCvGErWU2W1H6gE0BQEWlaLU-174CfN2T53u1uP6B2mebLRbKcw2unOZBvMvzcpbMz3fGukUhIkrwFvDgFT_rHDMpux9sQYbcK8K4ZqvpBaLOjr_9CbvJtSrWcYcNYpwaSoVLunXP3sMuHwMAwFs2g1i1azaDVVa-Vf_d3ggf7jsQJv90Cx1QzOplisbI2TDMzF5cqs2Rr50AnJfwPBrqsM</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2032684254</pqid></control><display><type>article</type><title>The effect of iloprost and sildenafil, alone and in combination, on myocardial ischaemia and nitric oxide and irisin levels</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Yardim, Meltem ; Kalkan, Ali Kemal ; Aydin, Suna ; Eren, Mehmet Nesimi ; Temizturk, Zeki ; Aydin, Suleyman ; Azboy, Davut ; Kuloglu, Tuncay</creator><creatorcontrib>Yardim, Meltem ; Kalkan, Ali Kemal ; Aydin, Suna ; Eren, Mehmet Nesimi ; Temizturk, Zeki ; Aydin, Suleyman ; Azboy, Davut ; Kuloglu, Tuncay</creatorcontrib><description>Aim: Insufficient oxygen supply to organs and tissues due to reduced arterial or venous blood flow results in ischaemia, during which, although ATP production stops, AMP and adenosine continue to be produced from ATP. The fate of irisin, which causes the production of heat instead of ATP during ischaemia, is unknown. Iloprost and sildenafil are two pharmaceutical agents that mediate the resumption of reperfusion (blood supply) via vasodilatation during ischaemic conditions. Our study aimed to explore the effects of iloprost and sildenafil on irisin levels in the heart, liver and kidney tissues and whether these pharmaceutical agents had any impact on serum irisin and nitric oxide levels in rats with induced experimental myocardial ischaemia. Methods: The study included adult male Sprague-Dawley rats aged 10 months and weighing between 250 and 280 g. The animals were randomly allocated to eight groups, with five rats in each group. The groups were: sham (control), iloprost (ILO), sildenafil (SIL), ILO + SIL, myocardial ischaemia (MI), MI + ILO, MI + SIL and MI + ILO + SIL. The treatment protocols were implemented before inducing ischaemia, which was done by occluding the left coronary artery with a plastic ligature for 30 minutes. Following the reperfusion procedure, all rats were sacrificed after 24 hours, and their heart, liver and kidney tissues and blood samples were collected for analyses. An immunohistochemical method was used to measure the change in irisin levels, the ELISA method to quantify blood irisin levels, and Griess’ assay to determine nitric oxide (NO) levels in the serum and tissue. Myocardial ischaemia was confirmed based on the results of Masson’s trichrome staining, as well as levels of troponin and creatine kinase MB. Results: Irisin levels in biological tissue and serum dropped statistically significantly in the ischaemic group (MI), but were restored with ILO and SIL administration. Individual SIL administration was more potently restorative than individual ILO administration or the combined administration of the two agents. NO level, on the other hand, showed the opposite tendency, reaching the highest level in the MI group, and falling with the use of pharmaceutical agents. Conclusions: Individual or combined administration of ILO and SIL reduced myocardial ischaemia and NO levels, and increased irisin levels. Elevated levels of irisin obtained by drug administration could possibly contribute to accelerated wound recovery by local heat production. Sildenafil was more effective than iloprost in eliminating ischaemia and may be the first choice in offsetting the effects of ischaemia in the future.</description><identifier>ISSN: 1995-1892</identifier><identifier>EISSN: 1680-0745</identifier><identifier>DOI: 10.5830/CVJA-2017-025</identifier><identifier>PMID: 28906529</identifier><language>eng</language><publisher>South Africa: Clinics Cardive Publishing</publisher><subject>Adenosine Triphosphate - metabolism ; Animals ; Biochemistry ; Cardiovascular Topics ; Disease Models, Animal ; Education ; Energy Metabolism - drug effects ; Experiments ; Fibronectins - blood ; Glucose ; Heart surgery ; Hospitals ; Iloprost ; Iloprost - pharmacology ; Irisin ; Kidney - drug effects ; Kidney - metabolism ; Liver ; Liver - drug effects ; Liver - metabolism ; Male ; Medicine ; Myocardial ischaemia–reperfusion ; Myocardial Ischemia - blood ; Myocardial Ischemia - drug therapy ; Myocardial Ischemia - pathology ; Myocardial Ischemia - physiopathology ; Myocardial Reperfusion Injury - blood ; Myocardial Reperfusion Injury - pathology ; Myocardial Reperfusion Injury - physiopathology ; Myocardial Reperfusion Injury - prevention &amp; control ; Myocardium - metabolism ; Myocardium - pathology ; Nitric oxide ; Nitric Oxide - blood ; Pharmaceuticals ; Proteins ; Rats, Sprague-Dawley ; Rodents ; Sildenafil ; Sildenafil Citrate - pharmacology ; Vasodilation - drug effects ; Vasodilator Agents - pharmacology ; Wound healing</subject><ispartof>Cardiovascular Journal of Africa, 2017-11, Vol.28 (6), p.389-396</ispartof><rights>Copyright © 2015 Clinics Cardive Publishing. This work is licensed under the Creative Commons Attribution License ( https://creativecommons.org/licenses/by/3.0/ ) (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>Copyright © 2015 Clinics Cardive Publishing 2016</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c449t-3930a6df337fc2070c48405d80e91a03d82e52718a9df15009104ea218919d703</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5885053/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5885053/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28906529$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yardim, Meltem</creatorcontrib><creatorcontrib>Kalkan, Ali Kemal</creatorcontrib><creatorcontrib>Aydin, Suna</creatorcontrib><creatorcontrib>Eren, Mehmet Nesimi</creatorcontrib><creatorcontrib>Temizturk, Zeki</creatorcontrib><creatorcontrib>Aydin, Suleyman</creatorcontrib><creatorcontrib>Azboy, Davut</creatorcontrib><creatorcontrib>Kuloglu, Tuncay</creatorcontrib><title>The effect of iloprost and sildenafil, alone and in combination, on myocardial ischaemia and nitric oxide and irisin levels</title><title>Cardiovascular Journal of Africa</title><addtitle>Cardiovasc J Afr</addtitle><description>Aim: Insufficient oxygen supply to organs and tissues due to reduced arterial or venous blood flow results in ischaemia, during which, although ATP production stops, AMP and adenosine continue to be produced from ATP. The fate of irisin, which causes the production of heat instead of ATP during ischaemia, is unknown. Iloprost and sildenafil are two pharmaceutical agents that mediate the resumption of reperfusion (blood supply) via vasodilatation during ischaemic conditions. Our study aimed to explore the effects of iloprost and sildenafil on irisin levels in the heart, liver and kidney tissues and whether these pharmaceutical agents had any impact on serum irisin and nitric oxide levels in rats with induced experimental myocardial ischaemia. Methods: The study included adult male Sprague-Dawley rats aged 10 months and weighing between 250 and 280 g. The animals were randomly allocated to eight groups, with five rats in each group. The groups were: sham (control), iloprost (ILO), sildenafil (SIL), ILO + SIL, myocardial ischaemia (MI), MI + ILO, MI + SIL and MI + ILO + SIL. The treatment protocols were implemented before inducing ischaemia, which was done by occluding the left coronary artery with a plastic ligature for 30 minutes. Following the reperfusion procedure, all rats were sacrificed after 24 hours, and their heart, liver and kidney tissues and blood samples were collected for analyses. An immunohistochemical method was used to measure the change in irisin levels, the ELISA method to quantify blood irisin levels, and Griess’ assay to determine nitric oxide (NO) levels in the serum and tissue. Myocardial ischaemia was confirmed based on the results of Masson’s trichrome staining, as well as levels of troponin and creatine kinase MB. Results: Irisin levels in biological tissue and serum dropped statistically significantly in the ischaemic group (MI), but were restored with ILO and SIL administration. Individual SIL administration was more potently restorative than individual ILO administration or the combined administration of the two agents. NO level, on the other hand, showed the opposite tendency, reaching the highest level in the MI group, and falling with the use of pharmaceutical agents. Conclusions: Individual or combined administration of ILO and SIL reduced myocardial ischaemia and NO levels, and increased irisin levels. Elevated levels of irisin obtained by drug administration could possibly contribute to accelerated wound recovery by local heat production. Sildenafil was more effective than iloprost in eliminating ischaemia and may be the first choice in offsetting the effects of ischaemia in the future.</description><subject>Adenosine Triphosphate - metabolism</subject><subject>Animals</subject><subject>Biochemistry</subject><subject>Cardiovascular Topics</subject><subject>Disease Models, Animal</subject><subject>Education</subject><subject>Energy Metabolism - drug effects</subject><subject>Experiments</subject><subject>Fibronectins - blood</subject><subject>Glucose</subject><subject>Heart surgery</subject><subject>Hospitals</subject><subject>Iloprost</subject><subject>Iloprost - pharmacology</subject><subject>Irisin</subject><subject>Kidney - drug effects</subject><subject>Kidney - metabolism</subject><subject>Liver</subject><subject>Liver - drug effects</subject><subject>Liver - metabolism</subject><subject>Male</subject><subject>Medicine</subject><subject>Myocardial ischaemia–reperfusion</subject><subject>Myocardial Ischemia - blood</subject><subject>Myocardial Ischemia - drug therapy</subject><subject>Myocardial Ischemia - pathology</subject><subject>Myocardial Ischemia - physiopathology</subject><subject>Myocardial Reperfusion Injury - blood</subject><subject>Myocardial Reperfusion Injury - pathology</subject><subject>Myocardial Reperfusion Injury - physiopathology</subject><subject>Myocardial Reperfusion Injury - prevention &amp; control</subject><subject>Myocardium - metabolism</subject><subject>Myocardium - pathology</subject><subject>Nitric oxide</subject><subject>Nitric Oxide - blood</subject><subject>Pharmaceuticals</subject><subject>Proteins</subject><subject>Rats, Sprague-Dawley</subject><subject>Rodents</subject><subject>Sildenafil</subject><subject>Sildenafil Citrate - pharmacology</subject><subject>Vasodilation - drug effects</subject><subject>Vasodilator Agents - pharmacology</subject><subject>Wound healing</subject><issn>1995-1892</issn><issn>1680-0745</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNpdkc1rFDEYhwdRbK0evUrAi0JH33zNJJdCWepHKXipXkM2ecdNySTrZLZY_OfNdNeinhKSJz_eX56meUnhnVQc3q--XZ63DGjfApOPmmPaKWihF_Jx3WstW6o0O2qelXIDwJjq5dPmiCkNnWT6uPl1vUGCw4BuJnkgIebtlMtMbPKkhOgx2SHEU2JjTnh_GhJxeVyHZOeQ0ynJiYx32dnJBxtJKG5jcQz2nk1hnoIj-Wfwh8dTKDUg4i3G8rx5MthY8MVhPWm-fri4Xn1qr758_Lw6v2qdEHpuueZgOz9w3g-OQQ9OKAHSK0BNLXCvGErWU2W1H6gE0BQEWlaLU-174CfN2T53u1uP6B2mebLRbKcw2unOZBvMvzcpbMz3fGukUhIkrwFvDgFT_rHDMpux9sQYbcK8K4ZqvpBaLOjr_9CbvJtSrWcYcNYpwaSoVLunXP3sMuHwMAwFs2g1i1azaDVVa-Vf_d3ggf7jsQJv90Cx1QzOplisbI2TDMzF5cqs2Rr50AnJfwPBrqsM</recordid><startdate>20171101</startdate><enddate>20171101</enddate><creator>Yardim, Meltem</creator><creator>Kalkan, Ali Kemal</creator><creator>Aydin, Suna</creator><creator>Eren, Mehmet Nesimi</creator><creator>Temizturk, Zeki</creator><creator>Aydin, Suleyman</creator><creator>Azboy, Davut</creator><creator>Kuloglu, Tuncay</creator><general>Clinics Cardive Publishing</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20171101</creationdate><title>The effect of iloprost and sildenafil, alone and in combination, on myocardial ischaemia and nitric oxide and irisin levels</title><author>Yardim, Meltem ; Kalkan, Ali Kemal ; Aydin, Suna ; Eren, Mehmet Nesimi ; Temizturk, Zeki ; Aydin, Suleyman ; Azboy, Davut ; Kuloglu, Tuncay</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c449t-3930a6df337fc2070c48405d80e91a03d82e52718a9df15009104ea218919d703</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Adenosine Triphosphate - metabolism</topic><topic>Animals</topic><topic>Biochemistry</topic><topic>Cardiovascular Topics</topic><topic>Disease Models, Animal</topic><topic>Education</topic><topic>Energy Metabolism - drug effects</topic><topic>Experiments</topic><topic>Fibronectins - blood</topic><topic>Glucose</topic><topic>Heart surgery</topic><topic>Hospitals</topic><topic>Iloprost</topic><topic>Iloprost - pharmacology</topic><topic>Irisin</topic><topic>Kidney - drug effects</topic><topic>Kidney - metabolism</topic><topic>Liver</topic><topic>Liver - drug effects</topic><topic>Liver - metabolism</topic><topic>Male</topic><topic>Medicine</topic><topic>Myocardial ischaemia–reperfusion</topic><topic>Myocardial Ischemia - blood</topic><topic>Myocardial Ischemia - drug therapy</topic><topic>Myocardial Ischemia - pathology</topic><topic>Myocardial Ischemia - physiopathology</topic><topic>Myocardial Reperfusion Injury - blood</topic><topic>Myocardial Reperfusion Injury - pathology</topic><topic>Myocardial Reperfusion Injury - physiopathology</topic><topic>Myocardial Reperfusion Injury - prevention &amp; control</topic><topic>Myocardium - metabolism</topic><topic>Myocardium - pathology</topic><topic>Nitric oxide</topic><topic>Nitric Oxide - blood</topic><topic>Pharmaceuticals</topic><topic>Proteins</topic><topic>Rats, Sprague-Dawley</topic><topic>Rodents</topic><topic>Sildenafil</topic><topic>Sildenafil Citrate - pharmacology</topic><topic>Vasodilation - drug effects</topic><topic>Vasodilator Agents - pharmacology</topic><topic>Wound healing</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yardim, Meltem</creatorcontrib><creatorcontrib>Kalkan, Ali Kemal</creatorcontrib><creatorcontrib>Aydin, Suna</creatorcontrib><creatorcontrib>Eren, Mehmet Nesimi</creatorcontrib><creatorcontrib>Temizturk, Zeki</creatorcontrib><creatorcontrib>Aydin, Suleyman</creatorcontrib><creatorcontrib>Azboy, Davut</creatorcontrib><creatorcontrib>Kuloglu, Tuncay</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Cardiovascular Journal of Africa</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yardim, Meltem</au><au>Kalkan, Ali Kemal</au><au>Aydin, Suna</au><au>Eren, Mehmet Nesimi</au><au>Temizturk, Zeki</au><au>Aydin, Suleyman</au><au>Azboy, Davut</au><au>Kuloglu, Tuncay</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The effect of iloprost and sildenafil, alone and in combination, on myocardial ischaemia and nitric oxide and irisin levels</atitle><jtitle>Cardiovascular Journal of Africa</jtitle><addtitle>Cardiovasc J Afr</addtitle><date>2017-11-01</date><risdate>2017</risdate><volume>28</volume><issue>6</issue><spage>389</spage><epage>396</epage><pages>389-396</pages><issn>1995-1892</issn><eissn>1680-0745</eissn><abstract>Aim: Insufficient oxygen supply to organs and tissues due to reduced arterial or venous blood flow results in ischaemia, during which, although ATP production stops, AMP and adenosine continue to be produced from ATP. The fate of irisin, which causes the production of heat instead of ATP during ischaemia, is unknown. Iloprost and sildenafil are two pharmaceutical agents that mediate the resumption of reperfusion (blood supply) via vasodilatation during ischaemic conditions. Our study aimed to explore the effects of iloprost and sildenafil on irisin levels in the heart, liver and kidney tissues and whether these pharmaceutical agents had any impact on serum irisin and nitric oxide levels in rats with induced experimental myocardial ischaemia. Methods: The study included adult male Sprague-Dawley rats aged 10 months and weighing between 250 and 280 g. The animals were randomly allocated to eight groups, with five rats in each group. The groups were: sham (control), iloprost (ILO), sildenafil (SIL), ILO + SIL, myocardial ischaemia (MI), MI + ILO, MI + SIL and MI + ILO + SIL. The treatment protocols were implemented before inducing ischaemia, which was done by occluding the left coronary artery with a plastic ligature for 30 minutes. Following the reperfusion procedure, all rats were sacrificed after 24 hours, and their heart, liver and kidney tissues and blood samples were collected for analyses. An immunohistochemical method was used to measure the change in irisin levels, the ELISA method to quantify blood irisin levels, and Griess’ assay to determine nitric oxide (NO) levels in the serum and tissue. Myocardial ischaemia was confirmed based on the results of Masson’s trichrome staining, as well as levels of troponin and creatine kinase MB. Results: Irisin levels in biological tissue and serum dropped statistically significantly in the ischaemic group (MI), but were restored with ILO and SIL administration. Individual SIL administration was more potently restorative than individual ILO administration or the combined administration of the two agents. NO level, on the other hand, showed the opposite tendency, reaching the highest level in the MI group, and falling with the use of pharmaceutical agents. Conclusions: Individual or combined administration of ILO and SIL reduced myocardial ischaemia and NO levels, and increased irisin levels. Elevated levels of irisin obtained by drug administration could possibly contribute to accelerated wound recovery by local heat production. Sildenafil was more effective than iloprost in eliminating ischaemia and may be the first choice in offsetting the effects of ischaemia in the future.</abstract><cop>South Africa</cop><pub>Clinics Cardive Publishing</pub><pmid>28906529</pmid><doi>10.5830/CVJA-2017-025</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1995-1892
ispartof Cardiovascular Journal of Africa, 2017-11, Vol.28 (6), p.389-396
issn 1995-1892
1680-0745
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5885053
source MEDLINE; EZB-FREE-00999 freely available EZB journals; PubMed Central; Alma/SFX Local Collection
subjects Adenosine Triphosphate - metabolism
Animals
Biochemistry
Cardiovascular Topics
Disease Models, Animal
Education
Energy Metabolism - drug effects
Experiments
Fibronectins - blood
Glucose
Heart surgery
Hospitals
Iloprost
Iloprost - pharmacology
Irisin
Kidney - drug effects
Kidney - metabolism
Liver
Liver - drug effects
Liver - metabolism
Male
Medicine
Myocardial ischaemia–reperfusion
Myocardial Ischemia - blood
Myocardial Ischemia - drug therapy
Myocardial Ischemia - pathology
Myocardial Ischemia - physiopathology
Myocardial Reperfusion Injury - blood
Myocardial Reperfusion Injury - pathology
Myocardial Reperfusion Injury - physiopathology
Myocardial Reperfusion Injury - prevention & control
Myocardium - metabolism
Myocardium - pathology
Nitric oxide
Nitric Oxide - blood
Pharmaceuticals
Proteins
Rats, Sprague-Dawley
Rodents
Sildenafil
Sildenafil Citrate - pharmacology
Vasodilation - drug effects
Vasodilator Agents - pharmacology
Wound healing
title The effect of iloprost and sildenafil, alone and in combination, on myocardial ischaemia and nitric oxide and irisin levels
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T22%3A45%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20effect%20of%20iloprost%20and%20sildenafil,%20alone%20and%20in%20combination,%20on%20myocardial%20ischaemia%20and%20nitric%20oxide%20and%20irisin%20levels&rft.jtitle=Cardiovascular%20Journal%20of%20Africa&rft.au=Yardim,%20Meltem&rft.date=2017-11-01&rft.volume=28&rft.issue=6&rft.spage=389&rft.epage=396&rft.pages=389-396&rft.issn=1995-1892&rft.eissn=1680-0745&rft_id=info:doi/10.5830/CVJA-2017-025&rft_dat=%3Cproquest_pubme%3E2032684254%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2032684254&rft_id=info:pmid/28906529&rft_sabinet_id=10520/EJC-b2be3f645&rfr_iscdi=true